| All patients | DD/ID genotype | II genotype | p* |
---|---|---|---|---|
 | N = 556 | N = 393 | N = 163 | DD/ID vs. II |
DCV | 1.89 ± 0.80 | 1.92 ± 0.80 | 1.83 ± 0.80 | 0.236 |
IRA - LM | 2 (0.4%) | 2 (0.5%) | 0 | 0.893 |
IRA - LAD (%) | 256 (46.0%) | 183 (46.6%) | 73 (44.8%) | 0.772 |
IRA - RCx (%) | 74 (13.3%) | 51 (13.0%) | 23 (14.1%) | 0.825 |
IRA - RCA (%) | 224 (40.3%) | 157 (39.9%) | 67 (41.1%) | 0.875 |
Initial TIMI | Â | Â | Â | Â |
0-1 | 380 (68.3%) | 270 (68.7%) | 110 (67.5%) | 0.050 |
2 | 91 (16.4%) | 71 (18.1%) | 20 (12.3%) | Â |
3 | 85 (15.3%) | 52 (13.2%) | 33 (20.2%) | Â |
TIMI after PCI | Â | Â | Â | Â |
0-1 | 13 (2.3%) | 10 (2.5%) | 3 (1.8%) | 0.830 |
2 | 51 (9.2%) | 37 (9.4%) | 14 (8.6%) | Â |
3 | 492 (88.5%) | 346 (88.0%) | 146 (89.6%) | Â |
EF (angiography) | 49.4 ± 12.2 | 49.3 ± 21.4 | 49.7 ± 12.0 | 0.644 |
EDV/BSA (mL/m2) | 62.4 ± 17.0 | 62.1 ± 16.9 | 63.2 ± 17.5 | 0.583 |
ESV/BSA (mL/m2) | 29.6 ± 12.5 | 30.0 ± 12.3 | 28.5 ± 13.0 | 0.049 |
EF (echo) (%) | 50.9 ± 11.3 | 50.2 ± 11.1 | 52.7 ± 11.7 | 0.006 |